ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of CT1812 in adults with mild to moderate Alzheimer's Disease (AD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease#887215
- TB006 Expanded Access (EA) Compassionate Use#841683
- An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease#915777
- BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease#966628
- Cognitive Rehabilitation of Glioma Patients#913042
Record · ID 1010029
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive